Avanza Fonder’s Insmed INSM Stock Holding History

Avanza Fonder’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.4K	Hold	445	–	–	﹤0.01%	453
2026 Q1	$72.8K	Sell	445 -259	-37%	-$39.8K	﹤0.01%	467
2025 Q4	$123K	Buy	+704	New	+$128K	﹤0.01%	451

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Avanza Fonder's INSM Position: Q2 2026 in Review

Avanza Fonder held its Insmed (INSM) position steady in Q2 2026 at 445 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Avanza Fonder first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $123K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Avanza Fonder held 445 shares of Insmed worth $47.4K as of Q2 2026.
Avanza Fonder left its Insmed share count unchanged in Q2 2026.
Insmed made up ﹤0.01% of Avanza Fonder's portfolio in Q2 2026, its #453 holding.
Avanza Fonder first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
Avanza Fonder's Insmed position peaked at $123K in Q4 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.